Lesley Portnoy and Novartis

Glancy Prongay & Murray LLP Continues its Investigation on Behalf of Novartis AG Investors (NVS) | Benzinga | 9/12/2019

Novartis AG (“Novartis” or the “Company”) (NYSE: NVS ) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll …

Glancy Prongay & Murray LLP Continues its Investigation on Behalf of Novartis AG Investors (NVS) | Financial Buzz | 9/11/2019

Novartis AG (“Novartis” or the “Company”) (NYSE: NVS ) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll …

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Novartis AG Investors (NVS) | Business Wire | 8/8/2019

Novartis AG (“Novartis” or the “Company”) (NYSE: NVS ) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll …